The study looked at skin samples from people with a tough form of psoriasis on the palms and soles and found that several inflammatory signals, including the peptide LL‑37, are higher in this condition compared to milder forms. It shows the IL‑17A pathway is especially active, but it doesn’t give any new tips for boosting health or performance outside of treating this skin disease.

Palmoplantar pustular psoriasis (PPPP) is a variant of psoriasis, which has significant negative impact on quality of life. The cellular and molecular inflammatory pathways involved in PPPP have not been well studied. Study the expression of cytokines and chemokines involved in the IL-17/IL-23 axis in palmoplantar pustular psoriasis and other difficult to treat psoriasis areas (palms, scalp, elbows and lower legs). Skin biopsies were performed on a total of 80 patients with PPPP, non-pustular palmoplantar psoriasis (NPPPP), or psoriasis located on elbows, knees and scalp as well as 10 healthy subjects. RT-PCR, immunohistochemistry and flow cytometry on cells extracted from skin biopsies were used to compare PPPP to other forms of psoriasis. There was a significant (p<0.05) increase in the expression of IL-1β, IL-6, LL-37, IL-19, IL-17A, CXCL1 and CXCL2 in PPPP as compared to NPPPP. However, there was no significant difference in expression of IL-23 in PPPP as compared to NPPPP and other forms of psoriasis. The proportion of IL-22⁺ but not IL-17A⁺ mast cells was higher in PPPP as compared to NPPPP (p<0.05). These results suggest that the IL-17A pathway may play a more important role in PPPP than in NPPPP.